South Africa

More bullying? J&J will be investigated for high TB drug prices and abuse of patent laws

By Mia Malan for the Bhekisisa Centre for Health Journalism

South Africa

Analysis finds SA was bullied into one-sided, imperial and immoral Covid-19 vaccine contracts

By Multi Stakeholder Group

Business Maverick

J&J must pay $18.8m in California talc-cancer trial

By Bloomberg

Maverick Citizen

Here's why SA will not be getting the new bivalent Sars-CoV-2 vaccines

By Adele Baleta

Maverick Citizen

HIV vaccine research set to change focus in wake of Mosaico disappointment

By Adele Baleta

South Africa

Second Pfizer booster shot available in SA for 50 and older

By Tamsin Metelerkamp

South Africa

Quest for antibiotics – new Cape Town centre to tackle antimicrobial resistance through drug discovery

By Tamsin Metelerkamp

South Africa

UK to end Covid curbs; South Africa registers 1,151 new cases

By Bloomberg

South Africa

South Africa has ‘a healthy pipeline of Covid therapies’, says Sahpra CEO

By Zukiswa Pikoli

South Africa

What we lose in the jostle to get vaccinated

By Christine Hobden and Heidi Matisonn

South Africa

Covid-19 booster shot roll-out off to a slow start thanks to festive season

By Tamsin Metelerkamp

Africa

The ABCs of DIY vaccines: Why tech transfer is a big thing

By Adèle Sulcas and Linda Pretorius